Newseria: – Our main product that we are currently focused on is a transdermal system that increases the bioavailability of active substances. First and foremost, it improves the patient’s comfort during therapy. Our daily tablet intake can be huge, and some patients have to take more than ten or even twenty tablets a day, so […]

MamStartup: Biotts, a company from Wrocław, has just received the “Lower Silesian Innovation Voucher” granted to enterprises to finance research services, consultations with scientific establishments and technology audits. Biotts is a Polish biotechnology company creating proprietary preparations and drug formulas based on extracts of natural origin, as well as proprietary carriers that increase the bioavailability […]

Our application under the “Lower Silesian Innovation Voucher” is successful. The grant under the programme is given to enterprises from Lower Silesia to finance research services, consultations with scientific establishments and technological audits. What is more, the scheme also finances R&D works on the implementation or development of products or technologies. We will use the […]

And so the 4th Health Challenges Congress in Katowice is over. The shortlist in the finals of the Start-UpMed competition included 11 innovative companies from the medical industry. During the congress, we presented our innovative transdermal drug delivery system that increases the bioavailability of active substances. The competition was to select and reward the most creative businesses that develop innovative, […]

We are pleased to announce that we have filed another patent application. This time for the “Cosmetic carrier, cosmetic composition and the use of composition in cosmetics”.The subject of the application is an innovative cosmetic carrier that actively backs the absorption of nutrients to the skin and accelerates skin regeneration. The sole owner of copyright […]

We are pleased to announce that on 10 January 2019 we filed with the Patent Office of the Republic of Poland an invention disclosure for the “A pharmaceutical carrier for active ingredients and a pharmaceutical composition containing it”.The subject of the application is the foundation of the MTC-Y technology developed by our Company. The sole […]